THE USE OF EBASTINE, A MAST CELL BLOCKER, FOR TREATMENT OF OLIGOZOOSPERMIA
- 1 January 2000
- journal article
- Published by Taylor & Francis in Archives of Andrology
- Vol. 44 (2) , 129-132
- https://doi.org/10.1080/014850100262290
Abstract
The effect of mast cell blocker (ebastine) on semen quality was evaluated in 15 idiopathic oligozoospermic males. Ten milligrams/day of ebastine was administered orally for 3 months. Nine cases (66.7%) showed definite improvement in the semen quality. The wives of 3 patients (20%) became pregnant within 6 months of the initial treatment. It would appear that mast cell blocker (ebastine) significantly improves semen quality in men with idiopathic oligozoospermia.Keywords
This publication has 4 references indexed in Scilit:
- Role of low-dose estrogen–testosterone combination therapy in men with oligospermiaFertility and Sterility, 1998
- EbastineDrugs, 1996
- The Use of Ketotifen, a Mast Cell Blocker, for Treatment of Oligo- and Asthenozoospermia*Andrologia, 1986
- Mastocytosis Occurring in the Testes From Patients With Idiopathic Male InfertilityFertility and Sterility, 1981